HCPCS code Q5135 — Inj, tyenne, 1 mg. Status: Active. Effective Oct 1, 2024. Source: CMS HCPCS Level II.

Q5135

Active

Inj, tyenne, 1 mg

Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Oct 1, 2024
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0784

MUE — Medically Unlikely Edits

Maximum units of Q5135 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 1200
Outpatient Hospital 1200
Practitioner Services 1200

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
65219-0584-01 Tyenne
65219-0586-04 Tyenne
65219-0590-04 Tyenne
65219-0592-10 Tyenne
65219-0594-20 Tyenne

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q4
    Inj, tyenne, 1 mg